Investigator Initiated Research Opportunities | Takeda Pharmaceuticals

Investigator Initiated Research


doctor smiling
We, along with our partner network, are committed to improving patient care through support of scientific advances in medicine and increasing understanding of important diseases. Our Investigator Initiated Research (IIR) program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest.
APPLY FOR NEW OR MANAGE ONGOING REQUEST

Areas of Interest


Questions about our IIR program?


Please contact

Disclaimer


Takeda and its alliance partners are committed to improving patient care by supporting scientific advances in medicine and increasing our understanding of important diseases. As part of this commitment, the IIR program supports innovative interventional and noninterventional and basic science studies that address important medical and scientific questions related to our compounds and therapeutic Areas of Interest (AOI).

IIR is defined as an unsolicited research study where the Investigator, organization or institution (academic, private, or governmental) serves as the Sponsor, and Takeda provides support only in the form of funding, study product, safety information and/or authorization to reference Takeda’s NDA or other regulatory submissions (e.g., IND). Takeda does not provide input in an IIR other than providing the above support.

Takeda reviews completed proposals both within and outside of the Areas of Interest (AOI) listed throughout this document.

All proposals will be evaluated in adherence with Takeda policies and all applicable laws and regulations. Decisions are based upon scientific merit as well as alignment with research areas of interest and availability of resources. Submission of a proposal does not imply or guarantee approval. Support of a study in no way implies any obligation toward or is any way connected to the recommendation or prescribing of products.